Clinical Trials Directory

Trials / Completed

CompletedNCT01987778

Health Effects of Resistance Training on Postmenopausal Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
65 (actual)
Sponsor
Ostergotland County Council, Sweden · Academic / Other
Sex
Female
Age
45 Years
Healthy volunteers
Not accepted

Summary

Today's women will live more than a third of their lives after menopause, i.e. with a changed hormonal and metabolic state. Vasomotor symptoms like hot flushes and sweating are reported by about 75% of all women around menopause and may impair well-being, mental state, daily activities and night sleep. Vasomotor symptoms are less prevalent in women who participate in regular physical exercise. It is, however, still uncertain if physical exercise reduces vasomotor symptoms. The purpose of this randomized controlled study is to establish possible beneficial health effects from 15 weeks of supervised resistance training (RT) on postmenopausal women. End-points include effects from RT in postmenopausal women on 1. clinical outcomes (number and severity of vasomotor symptoms, Health-Related quality of Life (HRQoL), Body Mass Index (BMI), abdominal height, muscle strength and mass, browning of fat), 2. diagnostic variables (production of myokines as irisin, immunological markers) and 3. genetic variables (length of telomeres). The control group will be offered resistance training after the intervention period.

Detailed description

The first phase is planned as a pilot-study including 20 women participating for 15 weeks. Thereafter an evaluation of the sample size and the study methodology will be made.

Conditions

Interventions

TypeNameDescription
OTHERResistance trainingResistance training supervised and individualized by an experienced physiotherapist. First the relative load will be lighter during three weeks, thereafter the intensity and load will be increased over another 12 weeks.

Timeline

Start date
2013-11-01
Primary completion
2017-03-02
Completion
2020-06-01
First posted
2013-11-19
Last updated
2021-02-24

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01987778. Inclusion in this directory is not an endorsement.